Urinary Bladder, Overactive Clinical Trials

118 clinical trials for Urinary Bladder, Overactive across international registries, including 10 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Does Use of a Pre-Procedure Educational Video for Urodynamic Testing Reduces Anxiety? — RECRUITING · NA
• Comparison of the Efficacy of Perineal and Intravaginal Electrical Stimulation in Women With Idiopathic Overactive Bladder — RECRUITING · NA
• NXT Post-Market Clinical Follow-up — RECRUITING
• Vitamin D Treat-to-Target Strategy for Children With Overactive Bladder-Wet — RECRUITING · NA
• Ambulatory Long Length URodynamics Evaluation — RECRUITING · NA
• Efficacy of Combined Pharmacotherapy Versus Solifenacin With Vaginal Estrogen Cream for Women With Detrusor Overactivity — RECRUITING · PHASE4
• Evaluation the Efficacy Between Botox Injection and Combination Pharmacotherapy in Patients With Detrusor Overactivity — RECRUITING · PHASE4
• Efficacy of Solifenacin or Mirabegron With Local Estrogen Versus Combination Pharmacotherapy for Overactive Bladder — RECRUITING · PHASE4
• Elastographic Assessment of Suburethral Tissue in Continent and Incontinent Women — RECRUITING
• Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A — RECRUITING · PHASE4
• Treatment Efficacy for Overactive Bladder: Comparing Education, Biofeedback, and Nerve Stimulation — NOT_YET_RECRUITING · NA
• Low-Intensity Shock Wave Therapy for Refractory Overactive Bladder in Women — NOT_YET_RECRUITING · NA
• Wearables for the Bladder: an In-home Treatment Feasibility Pilot Study — ACTIVE_NOT_RECRUITING · NA
• Comparative Effectiveness of Initial OAB Treatment Options Among Older Women at High Risk of Falls — COMPLETED · PHASE1
• Comparison of Concurrent Endoscopic Prostate Surgery With Botox-A Injection and Postoperative Medical Therapy in BPH Patients With Overactive Bladder Symptoms — ACTIVE_NOT_RECRUITING
• INTIBIA Pivotal Study — ACTIVE_NOT_RECRUITING · NA
• FemPulse Therapy for Overactive Bladder in Women — COMPLETED · NA
• A Randomized, Placebo-controlled Trial of Nitrous Oxide During In-office Bladder Botox Injections — NOT_YET_RECRUITING · PHASE4
• Laser Therapy for Treatment of Urogenital Symptoms in Women — COMPLETED
• Unilateral Versus Bilateral Neuromodulation Tests in the Treatment of Refractory Idiopathic Overactive Bladder — COMPLETED · NA
• Long-term Follow-up Study of Patients Who Received EG110A, a Non-replicative Herpes Simplex Virus 1-derived Gene Therapy — NOT_YET_RECRUITING · PHASE1
• INvestigation of TENS Efficacy Versus Posterior Tibial Nerve Stimulation for Overactive Bladder — TERMINATED · NA
• The Effect of Nighttime Mirabegron, Solifenacin, Tolterodine, or Oxybutynin on Nocturia, Sexual Function, Autonomic Function, and Lower Urinary Tract Blood Flow Perfusion in Women With Overactive Bladder Syndrome: Randomized Controlled Trial — NOT_YET_RECRUITING · PHASE3
• Efficacy of Animated Videos to Foster Healthy Bladder Behaviors in Community Women — COMPLETED · NA
• Association With Low Compliance Bladder in Women With LUTS — COMPLETED
• Transcutaneous Medial Plantar Nerve Stimulation in Women With Idiopathic Overactive Bladder — NOT_YET_RECRUITING · NA
• A Study to Test the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder — COMPLETED · PHASE3
• A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment. — COMPLETED · PHASE3
• Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder — COMPLETED · PHASE3
• Study to Assess the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder — COMPLETED · PHASE3
• A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder — COMPLETED · PHASE3
• A Study to Investigate How Safe and Effective Solifenacin Solution is in Treating Children/Adolescents With Symptoms of Overactive Bladder (OAB) Who Completed Study 905-CL-076 — COMPLETED · PHASE3
• A Study of YM178 in Subjects With Symptoms of Overactive Bladder — COMPLETED · PHASE3
• Study to Test the Efficacy and Safety of YM178 in Subjects With Symptoms of Overactive Bladder — COMPLETED · PHASE2
• A Study to Evaluate Safety and Efficacy of YM178 in Patients With Overactive Bladder — COMPLETED · PHASE3
• A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Succinate Alone and in Combination for the Treatment of Overactive Bladder — COMPLETED · PHASE2
• A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin) — COMPLETED · PHASE3
• A Study to Investigate How Effective and Safe Solifenacin Succinate Suspension is in Treating Children/Adolescents Aged 5 to Less Than 18 Years With Symptoms of Overactive Bladder (OAB) Compared to a Non-active Drug — COMPLETED · PHASE3
• A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Mirabegron Taken Together, or Separately, in Subjects With Symptoms of Overactive Bladder — COMPLETED · PHASE3
• A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Routine Clinical Practice — COMPLETED
• A Study of YM178 in Patients With Symptomatic Overactive Bladder — COMPLETED · PHASE2
• This Was a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder — COMPLETED · PHASE3
• Single-dose Study to Assess Pharmacokinetics of Solifenacin Succinate Suspension in Children and Adolescents — COMPLETED · PHASE1
• A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB) — COMPLETED
• Transcutaneous Tibial Nerve Stimulation in Patients With Neurogenic Overactive Bladder After Stroke — OTHER · NA
• Comparison of the Efficacy of Transcutaneos Nerve Stimulations in Women With Idiopathic Overactive Bladder — OTHER · NA
• Effectiveness of Oral Boldo in Women With Overactive Bladder — OTHER · PHASE1
• Myrbetriq™ (Mirabegron) to Reduce Pain and Discomfort Following Ureteral Stent Placement — TERMINATED · PHASE2
• Transcutaneous Tibial Nerve Stimulation in Antimuscarinic Naive and Refractory Women With Idiopathic Overactive Bladder — OTHER · NA
• Prevention of Bladder Dysfunction in Acute Spinal Cord Injury — COMPLETED · PHASE4

Refine this search